A Single Nucleotide Variant in HNF-1β is associated with Maturity-Onset Diabetes of the Young in a Large Chinese Family
-
Peng ZHOU
,
Ran WEI
,
Zhenkui GUO
,
Haining ZHU
,
Desmond CAMPBELL
,
Qi LI
,
Xiaoqun XU
,
Junfu WANG
,
Meng LUAN
,
Xing CHEN
,
Gang CHEN
Abstract
Background: Maturity-onset diabetes of the young (MODY) is a heterogeneous entity of monogenic disorders characterized by autosomal dominant inheritance. Eleven genes were related, including HNF4α, GCK, HNF1α, IPF1, and HNF-1β, and various mutations are being reported.
Methods: To help the overall understanding of MODY-related pathologic mutations, we studied a large MODY family found in 2012, in Shandong, China, which contained 9 patients over 3 generations.DNA was extracted from the periphery blood samples of (i) 9 affected members, (ii) 17 unaffected members, and (iii) 1000 healthy controls. Three pooled samples were obtained by mixing equal quantity ofDNA of each individual within the each group. Totally 400 microsatellite markers across the whole genome were genotyped by capillary electrophoresis. The known MODY-related gene near the identified marker was sequenced to look for putative risk variants.
Results: Allelic frequency of marker D17S798 on chromosome 17q11.2 were significantly different (P<0.001) between the affected vs. unaffected members and the affected vs. healthy controls, but not between the unaffected members vs. healthy controls. MODY5-related gene, hepatocyte nuclear factor-1β (HNF-1β) on 17q12 near D17S798 became the candidate gene. A single nucleotide variant (SNV) of C77T in the non-coding area of exon 1 of HNF-1β was found to be related to MODY5.
Conclusion: This novel SNV of HNF-1β contributes to the diabetes development in the family through regulating gene expression most likely. The findings help presymptomatic diagnosis, and imply that mutations in the non-coding areas, as well as in the exons, play roles in the etiology of MODY.
Fajans SS, Bell GI (2011). MODY History, genetics, pathophysiology, and clinical decision making. Diabetes Care, 34:1878-1884.
Fajans SS, Bell GI, Polonsky KS (2001). Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Eng J Med, 345:971-980.
Froguel P, Velho G (1999). Molecular genetics of maturity-onset diabetes of the young. Trends Endocrinol Metab, 10(4):142-146.
Froguel P, Vaxillaire M, Sun F, Velho G, Zouali H, Butel M, Lesage S, Vionnet N, Clement K, Fougerousse F (1992). Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature, 356:162-164.
Staffers DA, Ferrer J, Clarke WL, Habener JF (1997). Early-onset type-ll diabetes mellitus (MODY4) linked to IPF1. Nat Genet, 17:138-139.
Yamagata K, Oda N, Kaisaki PJ, Menzel S, Furuta H, Vaxillaire M, Southam L, Cox RD, Lathrop GM, Boriraj VV (1996). Mutations in the hepatocyte nuclear factor-1 alpha gene in maturity-onset diabetes of the young (MODY3). Nature, 384:458-60.
Kanwal A, Fazal S, Ismail M, Naureen N (2011). A narrative insight to maturity-onset diabetes of the young. Clin Rev Opin, 3:6-13.
Shields B, Hicks S, Shepherd M, Colclough K, Hattersley A, Ellard S (2010). Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia, 53:2504-2508.
Osbak KK, Colclough K, Saint‐Martin C, Beer NL, Bellanné‐Chantelot C, Ellard S, Gloyn AL (2009). Update on mutations in glucokinase (GCK), which cause maturity‐onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia. Hum Mutat, 30:1512-1526.
Frayling TM, Lindgren CM, Chevre JC, Menzel S, Wishart M, Benmezroua Y, Brown A, Evans JC, Rao PS, Dina C (2003). A Genome-Wide Scan in Families With Maturity-Onset Diabetes of the Young Evidence for Further Genetic Heterogeneity. Diabetes, 52:872-881.
Rosenbloom AL, Joe JR, Young RS, Winter WE (1999). Emerging epidemic of type 2 diabetes in youth. Diabetes Care, 22:345-354.
Frayling TM, Evans JC, Bulman MP, Pearson E, Allen L, Owen K, Bingham C, Hannemann M, Shepherd M, Ellard S (2001). beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors. Diabetes, 50:S94.
Ng MC, Lee S-C, Ko GT, Li JK, So W-Y, Hashim Y, Barnett AH, Mackay IR, Critchley JA, Cockram CS (2001). Familial Early-Onset Type 2 Diabetes in Chinese Patients Obesity and genetics have more significant roles than autoimmunity. Diabetes Care, 24:663-671.
American Diabetes Association (2008). Diagnosis and classification of diabetes mellitus. Diabetes Care, 31:S55-S60.
Liu Y, Chen G, Norton N, Liu W, Zhu H, Zhou P, Luan M, Yang S, Chen X, Carroll L (2009). Whole genome association study in a homogenous population in Shandong peninsula of China reveals JARID2 as a susceptibility gene for schizophrenia. J Biomed Biotechnol, 2009:536918.
Damji K, Gallione C, Allingham R, Slotterbeck B, Guttmacher A, Pasyk K, Vance J, Pericak-Vance M, Speer M, Marchuk D (1998). Quantitative DNA pooling to increase the efficiency of linkage analysis in autosomal dominant disease. Hum Genet, 102:207-212.
Dib C, Fauré S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, Marc S, Kazan J, Seboun E (1996). A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature, 380:152-154.
Sham P, Curtis D (1995). Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet, 59:97-105.
Bowman P, Flanagan S, Edghill E, Damhuis A, Shepherd M, Paisey R, Hattersley A, Ellard S (2012). Heterozygous ABCC8 mutations are a cause of MODY. Diabetologia, 55:123-127.
Bonnefond A, Philippe J, Durand E, Dechaume A, Huyvaert M, Montagne L, Marre M, Balkau B, Fajardy I, Vambergue A (2012). Whole-exome sequencing and high throughput genotyping identified KCNJ11 as the thirteenth MODY gene. PloS One, 7:e37423.
Chevre J-C, Hani E, Boutin P, Vaxillaire M, Blanche H, Vionnet N, Pardini V, Timsit J, Larger E, Charpentier G (1998). Mutation screening in 18 Caucasian families suggest the existence of other MODY genes. Diabetologia, 41:1017-1023.
Ellard S, Colclough K (2006). Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity‐onset diabetes of the young. Hum Mutat, 27:854-869.
Johansen A, Ek J, Mortensen H, Pedersen O, Hansen T (2005). Half of clinically defined maturity-onset diabetes of the young patients in Denmark do not have mutations in HNF4A, GCK, and TCF1. J Clin Endocr Metab, 90:4607-4614.
Estalella I, Rica I, Nanclares D, Perez G, Bilbao JR, Vazquez JA, San Pedro JI, Busturia MA, Castaño L (2007). Mutations in GCK and HNF‐1α explain the majority of cases with clinical diagnosis of MODY in Spain. Clin Endocrinol (Oxf), 67:538-546.
Furuzawa GK, Giuffrida FM, Oliveira CS, Chacra AR, Dib SA, Reis AF (2008). Low prevalence of MODY2 and MODY3 mutations in Brazilian individuals with clinical MODY phenotype. Diabetes Res Clin Pract, 81:e12-e14.
Yorifuji T, Fujimaru R, Hosokawa Y, Tamagawa N, Shiozaki M, Aizu K, Jinno K, Maruo Y, Nagasaka H, Tajima T (2012). Comprehensive molecular analysis of Japanese patients with pediatric‐onset MODY‐type diabetes mellitus. Pediatr Diabetes, 13:26-32.
Hwang JS, Shin CH, Yang SW, young Jung S, Huh N (2006). Genetic and clinical characteristics of Korean maturity-onset diabetes of the young (MODY) patients. Diabetes Res Clin Pract, 74:75-81.
Xu JY, Dan QH, Chan V, Wat NM, Tam S, Tiu SC, Lee KF, Siu SC, Tsang MW, Fung LM (2005). Genetic and clinical characteristics of maturity-onset diabetes of the young in Chinese patients. Eur J Hum Genet, 13:422-427.
Xu JY, Dan QH, Chan V, Wat NM, Tam S, Tiu SC, Lee KF, Siu SC, Tsang MW, Fung LM (2004). Genetic and clinical characteristics of maturity-onset diabetes of the young in Chinese patients. Eur J Hum Genet, 13:422-427.
Wang C, Fang Q, Zhang R, Lin X, Xiang K (2004). Scanning for MODY5 gene mutations in Chinese early onset or multiple affected diabetes pedigrees. Acta Diabetol, 41:137-145.
Wentworth J, Lukic V, Bahlo M, Finlay M, Nguyen C, Morahan G, Harrison L (2014). Maturity‐onset diabetes of the young type 5 in a family with diabetes and mild kidney disease diagnosed by whole exome sequencing. Intern Med J, 44:1137-1140.
Jo W, Sano H, Sudo A, Matsunami Y, Kawamura N, Tajima T (2012). A Case of Novel Mutation of HNF1B in Maturity-onset Diabetes of the Young Type 5 (MODY5). Clin Pediatr Endocrinol, 21(3):53-55.
Mancusi S, La Manna A, Bellini G, Scianguetta S, Roberti D, Casale M, Rossi F, Della Ragione F, Perrotta S (2013). HNF-1beta mutation affects PKD2 and SOCS3 expression causing renal cysts and diabetes in MODY5 kindred. J Nephrol, 26:207-212.
Banin P, Giovannini M, Raimondi F, D'Annunzio G, Sala S, Salina A, Aloi C, De Sanctis V (2011). A novel hepatocyte nuclear factor-1β (MODY 5) gene mutation in a Romanian boy with pancreatic calcifications, renal and hepatic dysfunction. Georgian Med News, 193:55-60.
Kim EK, Lee JS, Cheong HI, Chung SS, Kwak SH, Park KS (2014). Identification and Functional Characterization of P159L Mutation in HNF1B in a Family with Maturity-Onset Diabetes of the Young 5 (MODY5). Genomics Inform, 12(4):240-246.
Mancusi S, La Manna A, Bellini G, Scianguetta S, Roberti D, Casale M, Rossi F, Della Ragione F, Perrotta S (2012). HNF-1β mutation affects PKD2 and SOCS3 expression causing renal cysts and diabetes in MODY5 kindred. J Nephrol, 26(1):207-12.
Raile K, Klopocki E, Holder M, Wessel T, Galler A, Deiss D, Muller D, Riebel T, Horn D, Maringa M (2009). Expanded clinical spectrum in hepatocyte nuclear factor 1b-maturity-onset diabetes of the young. J Clin Endocrinol Metab, 94(7):2658-64.
Chen Y-z, Gao Q, Zhao X-z, Chen Y-Z, Bennett CL, Xiong X-S, Mei C-L, Shi Y-Q, Chen X-M (2010). Systematic review of TCF2 anomalies in renal cysts and diabetes syndrome/maturity onset diabetes of the young type 5. Chin Med J (Engl), 123:3326-3333.
Parkin NT, Cohen EA, Darveau A, Rosen C, Haseltine W, Sonenberg N (1988). Mutational analysis of the 5'non-coding region of human immunodeficiency virus type 1: effects of secondary structure on translation. EMBO J, 7(9):2831-7.
Shatkin A, Banerjee A, Both G, Furuichi Y, Muthukrishnan S (1976) Dependence of translation on 5'-terminal methylation of mRNA. Fed Proc, 35(11):2214-7.
| Files | ||
| Issue | Vol 45 No 2 (2016) | |
| Section | Original Article(s) | |
| Keywords | ||
| Maturity-onset diabetes of the young (MODY) Maturity-onset diabetes of the young type 5 (MODY5) Hepatic nuclear factor 1 beta (HNF1β) | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
